Patents by Inventor Kambiz Mousavi

Kambiz Mousavi has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • HUMAN CYTOMEGALOVIRUS RNA VACCINES
    Publication number: 20230116376
    Abstract: The disclosure describes HCMV ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.
    Type: Application
    Filed: August 12, 2022
    Publication date: April 13, 2023
    Applicant: ModernaTX, Inc.
    Inventors: Giuseppe Ciaramella, Shinu John, Kambiz Mousavi
  • Human cytomegalovirus RNA vaccines
    Patent number: 11484590
    Abstract: The disclosure describes HCMV ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.
    Type: Grant
    Filed: March 27, 2020
    Date of Patent: November 1, 2022
    Assignee: ModernaTX, Inc.
    Inventors: Giuseppe Ciaramella, Shinu John, Kambiz Mousavi
  • HUMAN CYTOMEGALOVIRUS RNA VACCINES
    Publication number: 20200246453
    Abstract: The disclosure describes HCMV ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.
    Type: Application
    Filed: March 27, 2020
    Publication date: August 6, 2020
    Applicant: ModernaTX, Inc.
    Inventors: Giuseppe Ciaramella, Shinu John, Kambiz Mousavi
  • Human cytomegalovirus RNA vaccines
    Patent number: 10716846
    Abstract: The disclosure describes HCMV ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.
    Type: Grant
    Filed: June 24, 2019
    Date of Patent: July 21, 2020
    Assignee: ModernaTX, Inc.
    Inventors: Giuseppe Ciaramella, Shinu John, Kambiz Mousavi
  • HUMAN CYTOMEGALOVIRUS RNA VACCINES
    Publication number: 20190321464
    Abstract: The disclosure describes HCMV ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.
    Type: Application
    Filed: June 24, 2019
    Publication date: October 24, 2019
    Applicant: ModernaTX, Inc.
    Inventors: Giuseppe Ciaramella, Shinu John, Kambiz Mousavi
  • Human cytomegalovirus RNA vaccines
    Patent number: 10383937
    Abstract: HCMV ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.
    Type: Grant
    Filed: June 12, 2018
    Date of Patent: August 20, 2019
    Assignee: ModernaTX, Inc.
    Inventors: Giuseppe Ciaramella, Shinu John, Kambiz Mousavi
  • MULTIMERIC MRNA
    Publication number: 20190008887
    Abstract: Aspects of the disclosure relate to multimeric molecules and methods of producing the same. In some embodiments, the multimeric molecules comprise at least two nucleic acid molecules (e.g., mRNA molecules) joined by non-covalent bonds between non-coding regions.
    Type: Application
    Filed: July 29, 2016
    Publication date: January 10, 2019
    Applicant: ModernaTX Inc.
    Inventors: Kambiz Mousavi, Cosmin Mihai
  • HUMAN CYTOMEGALOVIRUS RNA VACCINES
    Publication number: 20180271975
    Abstract: The disclosure describes HCMV ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.
    Type: Application
    Filed: June 12, 2018
    Publication date: September 27, 2018
    Applicant: ModernaTX, Inc.
    Inventors: Giuseppe Ciaramella, Shinu John, Kambiz Mousavi
  • MULTIMERIC MRNA
    Publication number: 20180273977
    Abstract: Aspects of the disclosure relate to multimeric molecules and methods of producing the same. In some embodiments, the multimeric molecules comprise at least two nucleic acid molecules (e.g., mRNA molecules) joined by non-covalent bonds between non-coding regions.
    Type: Application
    Filed: June 6, 2018
    Publication date: September 27, 2018
    Applicant: ModernaTX, Inc.
    Inventors: Kambiz Mousavi, Cosmin Mihai
  • Human cytomegalovirus RNA vaccines
    Patent number: 10064935
    Abstract: The disclosure describes HCMV ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.
    Type: Grant
    Filed: August 11, 2017
    Date of Patent: September 4, 2018
    Assignee: ModernaTX, Inc.
    Inventors: Giuseppe Ciaramella, Shinu John, Kambiz Mousavi
  • HUMAN CYTOMEGALOVIRUS RNA VACCINES
    Publication number: 20180028645
    Abstract: The disclosure relates to HCMV ribonucleic acid (RNA) vaccines, as well as methods of using the vaccines and compositions comprising the vaccines.
    Type: Application
    Filed: August 11, 2017
    Publication date: February 1, 2018
    Applicant: ModernaTX, Inc.
    Inventors: Giuseppe Ciaramella, Shinu John, Kambiz Mousavi